Navigation Links
Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
Date:8/23/2007

SEATTLE, Aug. 23 /PRNewswire/ -- Amnis Corporation announced today the release of two major upgrades to its ImageStream system including the Commercial release of a multilaser capability and the Beta release of a new technology for dramatically extending the depth of field well beyond conventional optical limitations.

The Multilaser upgrade provides the customer with the flexibility of adding two additional lasers including a 405nm (violet) laser and a 658nm (red) laser. These lasers provide for increased experimental flexibility and sophistication by greatly expanding the fluorescent dye selection available to the customer. The upgrade is accompanied by a novel enhancement to the optical system which provides precise chromatic correction for lower wavelength dyes excited by the 405nm laser. The enhancement enables high resolution imagery resulting from fluorescence excitation from all three lasers to be captured simultaneously across the entire visible spectrum. Customers who purchase the 405nm laser can now perform cell cycle, mitotic analysis and other experiments incorporating the widely-used DNA binding dyes DAPI and Hoechst. The 658nm red laser provides similar advantages for a broad range of red fluorescent dyes. The laser options have been designed for field-based installation and are currently being installed at existing customer sites throughout the world. New instruments are also being shipped per customer order with one, two or all three lasers installed.

The Extended Depth of Field (EDF) upgrade, currently in Beta testing at seven customer sites, has demonstrated up to a 10 fold increase depth of field allowing cellular structures to be imaged in crisp focus at positions well beyond the limitations of conventional imaging techniques. The EDF technology employs a Wavefront Coded(TM) optical element, developed by CDM Optics of Boulder, Colorado, operating in concert with rapid optical deconvolution algorithms developed by Amnis Corporation. The EDF option was specifically developed to address emerging research and clinical applications in high throughput cellular genetics. William Ortyn, Amnis COO, says "We are extremely pleased with the results of the this work. We now have several ongoing collaborations directed toward clinical testing of the ImageStream with the EDF option." to enable the early detection of cancer." Dr. David Basiji, Amnis CEO, states "The new capabilities enabled by both the Multilaser and EDF options bring new strengths to the platform to better serve our customer base. These options, in conjunction with our FISHIS(R) technology, also begin to lay the foundation for the advancement of the platform into the clinical marketplace."

Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The ImageStream system generates six high resolution microscopic images of cells as they flow through the instrument at rates up to 300 cells per second. Offering a truly unique combination of the visual power of microscopy and the statistical power of flow cytometry, the ImageStream system enables scientists to conduct highly advanced research in hematology, immunology and oncology.


'/>"/>
SOURCE Amnis Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems is ... log work hours, for employers to make sure the right employees are actually signing ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
Breaking Biology News(10 mins):